|
Status |
Public on Oct 07, 2015 |
Title |
Primary AML patient 1515 |
Sample type |
genomic |
|
|
Source name |
Primary AML patient
|
Organism |
Homo sapiens |
Characteristics |
tissue: blood dnmt3a mutation status: Wildtype
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA extracted by Phenol:Chloroform:Isoamylalcohol (Sigma)
|
Label |
Cy3/Cy5
|
Label protocol |
Standard Illumina labelling protocol
|
|
|
Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using High Scan SQ using standard recommended Illumina scanner setting
|
Data processing |
Genome Studio V2011.2. Unmethylated and methylated signal intensities included in signals_AML.txt file.
|
|
|
Submission date |
Oct 14, 2014 |
Last update date |
Oct 07, 2015 |
Contact name |
Manel Esteller |
Organization name |
IDIBELL
|
Department |
PEBC
|
Lab |
Cancer Epigenetics
|
Street address |
Hospital Duran i Reynals Av. Gran Via s/n km, 2.7
|
City |
L'Hospitalet de Llobregat |
State/province |
Barcelona |
ZIP/Postal code |
08908 |
Country |
Spain |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE62298 |
Genome-scale profiling of the DNA methylation landscape in human AML patients |
GSE62303 |
DNA methylation landscape in AML |
|